276 related articles for article (PubMed ID: 28857423)
61. PIKfyve: Partners, significance, debates and paradoxes.
Shisheva A
Cell Biol Int; 2008 Jun; 32(6):591-604. PubMed ID: 18304842
[TBL] [Abstract][Full Text] [Related]
62. Lipid kinases VPS34 and PIKfyve coordinate a phosphoinositide cascade to regulate retriever-mediated recycling on endosomes.
Giridharan SSP; Luo G; Rivero-Rios P; Steinfeld N; Tronchere H; Singla A; Burstein E; Billadeau DD; Sutton MA; Weisman LS
Elife; 2022 Jan; 11():. PubMed ID: 35040777
[TBL] [Abstract][Full Text] [Related]
63. ArPIKfyve regulates Sac3 protein abundance and turnover: disruption of the mechanism by Sac3I41T mutation causing Charcot-Marie-Tooth 4J disorder.
Ikonomov OC; Sbrissa D; Fligger J; Delvecchio K; Shisheva A
J Biol Chem; 2010 Aug; 285(35):26760-26764. PubMed ID: 20630877
[TBL] [Abstract][Full Text] [Related]
64. Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion.
Ikonomov OC; Sbrissa D; Shisheva A
Am J Physiol Cell Physiol; 2006 Aug; 291(2):C393-404. PubMed ID: 16510848
[TBL] [Abstract][Full Text] [Related]
65. Inhibition of PIKfyve Leads to Lysosomal Disorders via Dysregulation of mTOR Signaling.
Xia J; Wang H; Zhong Z; Jiang J
Cells; 2024 May; 13(11):. PubMed ID: 38891085
[TBL] [Abstract][Full Text] [Related]
66. Cloning and subcellular localization of a human phosphatidylinositol 3-phosphate 5-kinase, PIKfyve/Fab1.
Cabezas A; Pattni K; Stenmark H
Gene; 2006 Apr; 371(1):34-41. PubMed ID: 16448788
[TBL] [Abstract][Full Text] [Related]
67. Bidirectional interconversion between PtdIns4P and PtdIns(4,5)P
Eramo MJ; Gurung R; Mitchell CA; McGrath MJ
Autophagy; 2021 May; 17(5):1287-1289. PubMed ID: 33879025
[TBL] [Abstract][Full Text] [Related]
68. The Lysosomal Storage Disorder Due to
Bao W; Wang X; Luo L; Ni R
Zebrafish; 2021 Jun; 18(3):175-183. PubMed ID: 33909505
[TBL] [Abstract][Full Text] [Related]
69. Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3,5-P2 production for endomembrane integrity.
Ikonomov OC; Sbrissa D; Mlak K; Kanzaki M; Pessin J; Shisheva A
J Biol Chem; 2002 Mar; 277(11):9206-11. PubMed ID: 11714711
[TBL] [Abstract][Full Text] [Related]
70. B-cell non-Hodgkin lymphoma: Selective vulnerability to PIKFYVE inhibition.
Gayle S; Landrette S; Beeharry N; Conrad C; Hernandez M; Beckett P; Ferguson SM; Xu T; Rothberg J; Lichenstein H
Autophagy; 2017 Jun; 13(6):1082-1083. PubMed ID: 28350209
[TBL] [Abstract][Full Text] [Related]
71. Severe Consequences of SAC3/FIG4 Phosphatase Deficiency to Phosphoinositides in Patients with Charcot-Marie-Tooth Disease Type-4J.
Shisheva A; Sbrissa D; Hu B; Li J
Mol Neurobiol; 2019 Dec; 56(12):8656-8667. PubMed ID: 31313076
[TBL] [Abstract][Full Text] [Related]
72. Loss of PIKfyve in platelets causes a lysosomal disease leading to inflammation and thrombosis in mice.
Min SH; Suzuki A; Stalker TJ; Zhao L; Wang Y; McKennan C; Riese MJ; Guzman JF; Zhang S; Lian L; Joshi R; Meng R; Seeholzer SH; Choi JK; Koretzky G; Marks MS; Abrams CS
Nat Commun; 2014 Sep; 5():4691. PubMed ID: 25178411
[TBL] [Abstract][Full Text] [Related]
73. Localization and insulin-regulated relocation of phosphoinositide 5-kinase PIKfyve in 3T3-L1 adipocytes.
Shisheva A; Rusin B; Ikonomov OC; DeMarco C; Sbrissa D
J Biol Chem; 2001 Apr; 276(15):11859-69. PubMed ID: 11112776
[TBL] [Abstract][Full Text] [Related]
74. Phosphatidylinositol 3,5-bisphosphate and Fab1p/PIKfyve underPPIn endo-lysosome function.
Dove SK; Dong K; Kobayashi T; Williams FK; Michell RH
Biochem J; 2009 Apr; 419(1):1-13. PubMed ID: 19272020
[TBL] [Abstract][Full Text] [Related]
75. Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death.
Martin S; Harper CB; May LM; Coulson EJ; Meunier FA; Osborne SL
PLoS One; 2013; 8(3):e60152. PubMed ID: 23544129
[TBL] [Abstract][Full Text] [Related]
76. SNX19 restricts endolysosome motility through contacts with the endoplasmic reticulum.
Saric A; Freeman SA; Williamson CD; Jarnik M; Guardia CM; Fernandopulle MS; Gershlick DC; Bonifacino JS
Nat Commun; 2021 Jul; 12(1):4552. PubMed ID: 34315878
[TBL] [Abstract][Full Text] [Related]
77. Reversible assembly and disassembly of V-ATPase during the lysosome regeneration cycle.
Sava I; Davis LJ; Gray SR; Bright NA; Luzio JP
Mol Biol Cell; 2024 May; 35(5):ar63. PubMed ID: 38446621
[TBL] [Abstract][Full Text] [Related]
78. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling.
Ramel D; Lagarrigue F; Pons V; Mounier J; Dupuis-Coronas S; Chicanne G; Sansonetti PJ; Gaits-Iacovoni F; Tronchère H; Payrastre B
Sci Signal; 2011 Sep; 4(191):ra61. PubMed ID: 21934107
[TBL] [Abstract][Full Text] [Related]
79. LIM kinase 1: evidence for a role in the regulation of intracellular vesicle trafficking of lysosomes and endosomes in human breast cancer cells.
Nishimura Y; Yoshioka K; Bernard O; Himeno M; Itoh K
Eur J Cell Biol; 2004 Aug; 83(7):369-80. PubMed ID: 15503860
[TBL] [Abstract][Full Text] [Related]
80. Rab9 GTPase regulates late endosome size and requires effector interaction for its stability.
Ganley IG; Carroll K; Bittova L; Pfeffer S
Mol Biol Cell; 2004 Dec; 15(12):5420-30. PubMed ID: 15456905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
